← Open Payments lookup

AKRITI PAHARI: Open Payments

NPI 1053193078 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$838 in 35 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $647 · 2025 $838

Food & beverage: $827Education: $12
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.11$332
Novo Nordisk Inc6$128
Exact Sciences Corporation4$107
Amgen Inc.4$71
Astellas Pharma US Inc3$70
AstraZeneca Pharmaceuticals LP2$48
Boehringer Ingelheim Pharmaceuticals, Inc.1$24
Merck Sharp & Dohme LLC1$16
Lilly USA, LLC1$14
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$14

Products named: FANAPT, HETLIOZ, Cologuard Collection Kit, OTEZLA, Veozah, Wegovy, The Cologuard Plus Collection Kit, FARXIGA.

Industry payments across MD — which companies pay providers there.